HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.

作者: Hilde L.K Janssen , Karin M.G Haustermans , Debbie Sprong , Gerard Blommestijn , Ingrid Hofland

DOI: 10.1016/S0360-3016(02)03935-4

关键词: Hypoxia (medical)PathologyPimonidazoleTumor OxygenationImmunohistochemistryTumor hypoxiaPerfusionBlood vesselMedicineNeovascularization

摘要: PURPOSE: Tumor hypoxia measured by microelectrodes has been shown to indicate poor patient outcome. Here we investigated four potentially more widely applicable immunohistochemical parameters of tumor oxygenation and perfusion in human head-and-neck tumors. METHODS: Twenty patients with squamous cell carcinomas the head neck treated primary surgery were injected pimonidazole IdUrd evening before operation. Consecutive paraffin-embedded sections stained for blood vessels, pimonidazole, IdUrd, HIF-1alpha. labeling Ki-67 around individual vessels scored. The spatial relationship between HIF-1alpha was studied, as well distribution both markers a function distance from nearest vessel. RESULTS: Measurement all (diffusion-limited fraction, IdUrd-negative vessels) feasible, significant difference tumors found parameters. IdUrd-labeled cells absent some indicating lack perfusion, because these regions positive Ki-67. There correlation diffusion-limited fraction area images tumors, although no mean values per tumor. Colocalization low (0.02%-25%). Most expression profiles showed homogenous than pimonidazole. fractions 10 studied. CONCLUSIONS: Simultaneous measurements related are feasible (and easily applicable) resected different geographic distributions that might not be suitable marker chronic hypoxia. Each parameter will correlated outcome larger ongoing study on or without postoperative radiotherapy.

参考文章(55)
S. W. Rehmus, T. W. Secomb, D. Papahadjopoulos, K. Hong, M. W. Dewhirst, R. D. Braun, H. Kimura, Microvascular studies on the origins of perfusion-limited hypoxia The British journal of cancer. Supplement. ,vol. 27, pp. 247- ,(1996)
Peter Birner, Brigitte Gatterbauer, Georg Oberhuber, Monika Schindl, Karl Rössler, Axel Prodinger, Herbert Budka, Johannes A. Hainfellner, Expression of hypoxia-inducible factor-1α in oligodendrogliomas : Its impact on prognosis and on neoangiogenesis Cancer. ,vol. 92, pp. 165- 171 ,(2001) , 10.1002/1097-0142(20010701)92:1<165::AID-CNCR1305>3.0.CO;2-F
Hideo Kimura, Alessandro Weisz, Yukiko Kurashima, Kouichi Hashimoto, Tsutomu Ogura, Fulvio D'Acquisto, Raffaelo Addeo, Masatoshi Makuuchi, Hiroyasu Esumi, Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide Blood. ,vol. 95, pp. 189- 197 ,(2000) , 10.1182/BLOOD.V95.1.189
P L Olive, R E Durand, J A Raleigh, C Luo, C Aquino-Parsons, Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia. British Journal of Cancer. ,vol. 83, pp. 1525- 1531 ,(2000) , 10.1054/BJOC.2000.1489
Adrian L. Harris, Hypoxia — a key regulatory factor in tumour growth Nature Reviews Cancer. ,vol. 2, pp. 38- 47 ,(2002) , 10.1038/NRC704
R. K. Bruick, Oxygen Sensing Gets a Second Wind Science. ,vol. 295, pp. 807- 808 ,(2002) , 10.1126/SCIENCE.1069825
Patrick H. Maxwell, Michael S. Wiesener, Gin-Wen Chang, Steven C. Clifford, Emma C. Vaux, Matthew E. Cockman, Charles C. Wykoff, Christopher W. Pugh, Eamonn R. Maher, Peter J. Ratcliffe, The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature. ,vol. 399, pp. 271- 275 ,(1999) , 10.1038/20459
A C Begg, I Hofland, I Van Der Pavert, B Van Der Schueren, K Haustermans, Use of thymidine analogues to indicate vascular perfusion in tumours. British Journal of Cancer. ,vol. 83, pp. 899- 905 ,(2000) , 10.1054/BJOC.2000.1372